Pilot study tracks melatonin in pregnancy for future biomarker research

NCT ID NCT03014245

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how melatonin, a hormone known for sleep and as an antioxidant, changes during pregnancy. Researchers measured melatonin and its main byproduct in the blood of 60 women across each trimester. The goal was to gather basic information to help design larger studies on whether melatonin could be a marker for pregnancy complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREGNANCY TRANSIENT HYPERTENSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Aberdeen Maternity Hospital (NHS Grampian)

    Aberdeen, Aberdeenshire, AB25 2ZB, United Kingdom